News
Lupin Transfers Two Oncology Drug Candidates to Kaveri Therapeutics
Kaveri will advance Lupin’s two oncology drug candidates through global clinical trials.
ADDRESS: Street, City, Country
PHONE: +(123) 456 789
E-MAIL: your-email@mail.com
Kaveri will advance Lupin’s two oncology drug candidates through global clinical trials.
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 8447496924
HealthXploreIndia @2026. All Rights Reserved.
